Lumentum Holdings Inc.: Form 10-Q for the period ended Apr 3, 2021
Filed with the SEC on May 12, 2021 and accepted by EDGAR at May 12, 2021, 13:29 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-04-03. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-12-27 to 2021-04-03 | $419.5m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2020-06-28 to 2021-04-03 | $1.35bn | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Gross profit | 3 months2020-12-27 to 2021-04-03 | $185.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-06-28 to 2021-04-03 | $620.3m | us-gaap:GrossProfit |
| Research and development | 3 months2020-12-27 to 2021-04-03 | $57.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-06-28 to 2021-04-03 | $160.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-12-27 to 2021-04-03 | $65.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-06-28 to 2021-04-03 | $183.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-12-27 to 2021-04-03 | $266.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-06-28 to 2021-04-03 | $481.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-12-27 to 2021-04-03 | $16.4m | us-gaap:InterestExpense |
| Interest expense | 9 months2020-06-28 to 2021-04-03 | $48.7m | us-gaap:InterestExpense |
| Income tax | 3 months2020-12-27 to 2021-04-03 | $27.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-06-28 to 2021-04-03 | $58.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-12-27 to 2021-04-03 | $225.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-06-28 to 2021-04-03 | $375.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-12-27 to 2021-04-03 | $2.85 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-06-28 to 2021-04-03 | $4.78 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-12-27 to 2021-04-03 | $2.97 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-06-28 to 2021-04-03 | $4.97 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-12-27 to 2021-04-03 | 79,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-06-28 to 2021-04-03 | 78,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-06-28 to 2021-04-03 | $614.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-06-28 to 2021-04-03 | $66.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2020-06-28 to 2021-04-03 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-04-03 | $687.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-04-03 | $2.57bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-04-03 | $3.75bn | us-gaap:Assets |
| Current liabilities | At period end2021-04-03 | $674.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-04-03 | $1.58bn | us-gaap:Liabilities |
| Long-term debt | At period end2021-04-03 | $1.53bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2021-04-03 | $2.17bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001633978-21-000009. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.